Pure Global
Disease/Condition
1,235 Clinical Trials
10+ Countries

Chronic Obstructive Pulmonary Disease Clinical Trials Database - Free Access to 1,235 Studies

Access comprehensive clinical trial information for Chronic Obstructive Pulmonary Disease through Pure Global AI's free database. This collection includes 1,235 clinical trials across multiple phases including N/A, Phase 3, Phase 4. Currently, 189 trials are actively recruiting participants.

Research for Chronic Obstructive Pulmonary Disease is being conducted in United States of America, China, United Kingdom and 7+ other countries. Leading sponsors include AstraZeneca and Novartis Pharmaceuticals. Pure Global AI offers free access to clinical trial data from ClinicalTrials.gov, WHO ICTRP, and regional registries worldwide.

Free Database
Powered by Pure Global AI
840K+ Global Trials
Updated Daily
By Phase
N/A
776
Phase 3
114
Phase 4
112
Phase 2
91
Phase 1
55
By Status
Completed
683
Recruiting
189
Unknown
140
Not yet recruit...
131
Terminated
44
Top Countries
United States of America162
China147
United Kingdom97
France58
Germany53
Top Sponsors
AstraZeneca75
Novartis Pharmaceu...40
Chiesi Farmaceutic...32
Pearl Therapeutics...17
Schön Klinik Berch...16
Recent Trials
Latest clinical trials for Chronic Obstructive Pulmonary Disease
PHRR230822-006034
Phase 3
Ongoing

A Study to Evaluate Astegolimab in Participants With Chronic Obstructive Pulmonary Disease (ARNASA)

F. Hoffmann-La Roche Ltd.Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Czech;Republic;Denmark;Egypt;
NCT06395610
Phase 1
Recruiting

Effect of Erythromycin on the Absorption, Metabolism and Elimination of CHF6001 in Healthy Volunteers

Chiesi Farmaceutici S.p.A.Bulgaria
NCT06408285
Phase 1
Not yet recr...

A Study of TQC3927 Powder for Inhalation in Healthy Adult Subjects

Chia Tai Tianqing Pharmaceutic...China
NCT06390631
Recruiting

Effect of CPAP on Respiratory Load in COPD

State Key Laboratory of Respir...China
NCT06377410
Not yet recr...

Efficacy & Safety of Dry Powder Ivy Extract (Syrup Prospan) Versus NAC Among COPD Patients

National University of Malaysi...Malaysia
NCT06346678
Not yet recr...

Accuracy of Accuhaler Tester, Ellipta Tester and Turbutester in Patients With Chronic Obstructive Pulmonary Disease

Thammasat University
NCT06334575
Phase 4
Not yet recr...

Molecular Signatures Associated With Response to ICS Treatment in Patients With COPD Stratified by Eosinophil Levels

Maria Joyera RodríguezGermany,Netherlands,Spain,United Kingdom
NCT06326671
Phase 1
Recruitment ...

A Trial to Assess the Bioequivalence of Generic Tiotropium Bromide Inhalation Powder and Reference Product in Healthy Adult Participants Under Fasting Conditions (Pilot)

Chia Tai Tianqing Pharmaceutic...China
NCT06326658
Not yet recr...

Bufei Yishen Prescription on Patients With Frequent AECOPD in Stable Stage

Henan University of Traditiona...
NCT06335992
Recruiting

Tissue Regeneration in Patients With Chronic Obstructive Pulmonary Disease After an Exercise Intervention.

Uppsala UniversitySweden
NCT06332417
Recruiting

Combined Effects of Ba-Duan-Jin Based Deep Breathing Exercises and Forced Expiratory Technique

Riphah International Universit...Pakistan
NCT06330623
Recruiting

Developing Personalised Relative Physical Activity Thresholds in COPD.

University of LeicesterUnited Kingdom
NCT06308289
Recruiting

Combined Effects of Global Posture Re-education and Active Cycle of Breathing Technique in COPD

Riphah International Universit...Pakistan
NCT06314035
Not yet recr...

Decision Support on End-of-life Care Planning in Older Adults

National Taipei University of ...
NCT06297668
Phase 1
Not yet recr...

A Study to Assess the Pharmacokinetics and Safety of Budesonide, Glycopyrronium, & Formoterol (BGF) Metered Dose Inhaler (MDI) Hydrofluoroolefin (HFO) With a Spacer (Treatment B), BGF MDI Hydrofluoroalkane (HFA) With a Spacer (Treatment A), as Well as BGF MDI HFO Without a Spacer (Treatment C).

AstraZenecaGermany,United Kingdom
NCT06275230
Not yet recr...

Establishment of Human Lung Stem Cell Proliferation System and Organoid Construction in COPD

China-Japan Friendship Hospita...
NCT06271408
Phase 1
Recruiting

Comparison of Bronchodilator Response From Three Different Aerosol Delivery Methods in Patients With COPD Using Hyperpolarized Xe 129 MRI Ventilation Imaging

Polarean, Inc.United States of America
NCT06282861
Phase 4
Recruiting

ANTES B+ Clinical Trial

Fundacio Privada Mon Clinic Ba...Spain
NCT06287476
Not yet recr...

Alveolar-capillary Reserve After Exercise in Chronic Obstructive Pulmonary Disease (COPD) (COP-DTPA)

Rigshospitalet, DenmarkDenmark
NCT06253013
Recruiting

CHARM-COPD Program of Care

University Health Network, Tor...Canada
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
About Chronic Obstructive Pulmonary Disease Research

Pure Global AI provides free access to 1,235 clinical trials studying Chronic Obstructive Pulmonary Disease, aggregated from major global registries including ClinicalTrials.gov, WHO ICTRP, and regional databases.

The trials span multiple phases, from early Phase 1 safety studies to large-scale Phase 3 efficacy trials, conducted across 10+ countries.

Top research sponsors include AstraZeneca, Novartis Pharmaceuticals, Chiesi Farmaceutici S.p.A., among others.

Quick Facts
Total Trials1,235
Countries10+
Sponsors10+
Recruiting189